Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05515276
Other study ID # Kilis 7 Aralik Üniversitesi
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 1, 2021
Est. completion date August 1, 2021

Study information

Verified date November 2023
Source Kilis 7 Aralik University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Background: Global guidelines recommend the use of personal protective equipment due to the high risk of contagiousness of COVID-19 disease. The increase in COVİD-19 patients in the last two years has increased the rate of use of latex gloves in nurses. It is not known how the increase in the use of latex gloves affects the complaints of latex allergy in nurses. Aim: The aim of this study is to determine the rates of latex glove use and allergic complaints related to the use of latex gloves during the COVID-19 pandemic in hospital nurses.


Description:

Background: Global guidelines recommend the use of personal protective equipment due to the high risk of contagiousness of COVID-19 disease. The increase in COVİD-19 patients in the last two years has increased the rate of use of latex gloves in nurses. It is not known how the increase in the use of latex gloves affects the complaints of latex allergy in nurses. Aim: The aim of this study is to determine the rates of latex glove use and allergic complaints related to the use of latex gloves during the COVID-19 pandemic in hospital nurses. Materials and Methods: Ethical and legal permissions were obtained before starting the research. Research; It was conducted in a descriptive and cross-sectional manner at Hatay Training and Research Hospital between May 15 and June 15, 2021. The sample of the study consisted of 448 nurses who volunteered to participate in the study. The data of the study were collected with data collection forms created by the researchers as a result of literature reviews. The data of the research were collected by the online questionnaire method. Analysis of the data was analyzed with appropriate statistical methods in SPSS 21.0 program. p<0.05 value was accepted for statistical significance.


Recruitment information / eligibility

Status Completed
Enrollment 64
Est. completion date August 1, 2021
Est. primary completion date July 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Over 18 years old - Working as a nurse in Hatay Training and Research Hospital, Working in Hatay training and research hospital for the last month according to the date of the research - Nurses who volunteered to participate in the study were included in the study. Exclusion Criteria: - Nurses who want to leave the study at any stage of the study after being included in the study

Study Design


Locations

Country Name City State
Turkey Islam Kilis

Sponsors (1)

Lead Sponsor Collaborator
Kilis 7 Aralik University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Identifying Information Form: The identifying information form consists of questions aimed at determining the age, gender, education status, department of work, nursing experience, experience in the last working department, glove selection, family history of atopy, personal history of atopy, crossfood allergies, latex glove usage, duration of glove use in a day, number of invasive procedures, presence of diagnosed latex allergy, measures taken to prevent latex allergy, awareness of nonlatex gloves, and complaints after contact with latex-containing products. 2023
Primary Allergic Symptoms Evaluation Form: The form consists of questions aimed at determining skin reactions and allergic symptoms such as itching, redness, swelling, hives, lesions, rash, contact dermatitis, swelling 7 around the mouth and throat, nasal discharge, itching, sneezing, itching, redness, watering of the eyes, shortness of breath, coughing, wheezing, fainting, feeling of faintness, loss of consciousness, thinking that existing symptoms are related to work, etc. 2023
See also
  Status Clinical Trial Phase
Terminated NCT02032056 - Effect of Probiotics in Reducing Infections and Allergies in Young Children During the Complementary Feeding Period N/A
Completed NCT01842711 - Cumulative Irritation Patch Test N/A
Completed NCT01633840 - New Validated Recipes for Double-blind Placebo-controlled Low Dose Food Challenges N/A
Completed NCT00554983 - Efficacy and Safety From a Recombinant Folding Variant of Bet v 1 Phase 3
Completed NCT00997971 - Growth, Tolerance in Healthy Infants Fed a Partially Hydrolyzed Rice Protein Phase 3
Completed NCT00331929 - Respiratory Health Study of Children in Kiryat Tivon N/A
Completed NCT00232518 - Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic Rhinoconjunctivitis N/A
Completed NCT00220753 - Air Cleaners for Children and Adolescents With Asthma and Dog Allergy N/A
Completed NCT04046731 - Neuromuscular Blocking Agents Utilized During Perioperative Hypersensitivity Evaluation N/A
Completed NCT04126096 - Negative Predictive Value and NIC of Beta-Lactam Antibiotics. N/A
Completed NCT04004351 - Treatment Modalities in Children and Adolescents Suffering From HDM-induced Allergic Rhinitis and/or Asthma
Not yet recruiting NCT05997784 - Study of Indoor Air Pollutants and Their Impact in Childhood Health and Wellbeing
Completed NCT04418999 - Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus Early Phase 1
Completed NCT04186949 - Early Origins of Allergy and Asthma
Completed NCT02127801 - Single Ascending-dose Study of the Efficacy, Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Participants Phase 1
Enrolling by invitation NCT05011071 - The Alberta BLOOM Premature Child Study
Not yet recruiting NCT06330974 - Allergy, Asthma, and Atopic Eczema in Finland
Completed NCT02596321 - A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma Phase 3
Completed NCT02306473 - The Leaky Lung Test Early Phase 1
Terminated NCT02601690 - Observational Analysis of T Cell Responses to SPIREs for Multiple Allergens in Subjects With Allergy in North America